Table 3.
Diagnostic and management concordance between three teledermatologists and one in-person dermatologist, grouped by Fitzpatrick skin types.
| Percentage agreement |
||
|---|---|---|
| Lighter skin (Fitzpatrick I–III) |
Darker skin (Fitzpatrick IV–VI) |
|
| Primary diagnosis | ||
| TD 1 | 57.5% (42/73) | 58.6% (51/87) |
| TD 2 | 52.2% (36/69) | 54.2% (45/83) |
| TD 3 | 50.0% (37/74) | 55.1% (43/78) |
| Overall | 53.2% (115/216) | 56.0% (139/248) |
| Any diagnosis | ||
| TD 1 | 93.2% (68/73) | 89.7% (78/87) |
| TD 2 | 84.1% (58/69) | 88.0% (73/83) |
| TD 3 | 85.1% (63/74) | 79.5% (62/78) |
| Overall | 87.5% (189/216) | 85.9% (213/248) |
| Diagnostic testing | ||
| TD 1 | 72.6% (53/73) | 77.0% (67/87) |
| TD 2 | 55.1% (38/69) | 57.8% (48/83) |
| TD 3 | 48.6% (36/74) | 42.3% (33/78) |
| Overall | 58.8% (127/216) | 59.7% (148/248) |
| Clinic-based therapy | ||
| TD 1 | 82.2% (60/73) | 82.8% (72/87) |
| TD 2 | 78.3% (54/69) | 79.5% (66/83) |
| TD 3 | 74.3% (55/74) | 79.5% (62/78) |
| Overall | 78.2% (169/216) | 80.6% (200/248) |
| Medical treatment | ||
| TD 1 | 75.3% (55/73) | 70.1% (61/87) |
| TD 2 | 63.8% (44/69) | 68.7% (57/83) |
| TD 3 | 68.9% (51/74) | 62.8% (49/78) |
| Overall | 69.4% (150/216) | 67.3% (167/248) |
TD: teledermatologist